FRNM — Freenome, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 2017526 ·
Last close
$9.82
Market Cap
$1.09B
52W High
$17.50
52W Low
$9.71
ADV30
802,338
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 27,879,000 | 27,429,000 | -37,949,000 | -38,269,000 | 507,053,000 | 78,558,000 | 1,770,189,000 |
| Sep 2025 | 1,035,000 | 424,000 | -65,258,000 | -64,469,000 | — | — | — |
Balance + Analyst (yfinance extras)
Retained Earnings
—
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$217,864,000
EBITDA
$-70,853,000
Free Cash Flow
—
Enterprise Value
$925,846,848
Total Cash
$429,972,000
Total Debt
$201,659,008
Shares Out
111,500,956
Trailing EPS
$-2.04
Book Value
$4.34
ROE
-35.9%
ROA
-10.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 30,409,000 | -223,469,000 | -219,343,000 | 507,053,000 | 1,770,189,000 | -1,263,136,000 | -110,669,000 |
| Dec 2024 | 2,882,000 | -291,973,000 | -274,421,000 | 551,920,000 | 1,606,937,000 | -1,055,017,000 | -196,367,000 |
TTM Snapshot
Revenues TTM
$3,091,435
NetIncome TTM
$-762,626
OpCashFlow TTM
—
Assets (Latest)
$85,828,386
Forward EPS
$-2.44
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AHCO | AdaptHealth Corp. | $1.03B | $7.53 | — |
| CSTL | CASTLE BIOSCIENCES INC | $1.02B | $32.98 | — |
| PNTG | Pennant Group, Inc. | $1.28B | $36.50 | — |
| INNV | InnovAge Holding Corp. | $1.29B | $9.42 | — |
| OMDA | Omada Health, Inc. | $872.90M | $14.08 | — |
News headlines (Yahoo Finance, 1h cache)
Freenome (FRNM) Q3 2026 Earnings Call Transcript
2026-11-17 19:17 · Yahoo
Freenome to Participate in the Piper Sandler 38th Annual Healthcare Conference
2026-11-17 14:00 · Yahoo
Freenome Reports Third Quarter 2026 Financial Results
2026-11-10 21:01 · Yahoo
Freenome Soars 11% on Launch of Lung Cancer Blood Test That Makes Screening “Vastly Easier”
2026-10-23 18:23 · Yahoo
Tempus AI And 2 More AI Healthcare Stocks
2026-11-15 06:08 · Yahoo
Freenome Q3 Earnings Call Highlights
2026-11-11 02:14 · Yahoo
Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option
2026-10-20 12:30 · Yahoo
Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026
2026-10-15 20:29 · Yahoo
Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026
2026-10-11 17:00 · Yahoo
FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test
2026-08-12 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.